Ascendis Pharma A's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2025 to a ratio of 5.14, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the fourth quarter 2025. Average receivable collection period, for the Ascendis Pharma A in Dec 31 2025 quarter, has decreased to 71 days, compared to 84 days, in the 0 quarter.

If we take a look into Healthcare sector 606 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2025 from 0 to 4294.

What is Receivable Turnover Ratio?
What is Ascendis Pharma A Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ASND Receivables Turnover Ratio	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2024) IV. Quarter
Y / Y Receivable Change	-15 %	-15 %	-15 %	-15 %	369.29 %
Y / Y Revenue Change	49.14 %	292.89 %	362.52 %	2.14 %	26.24 %
Receivable Turnover Ratio (TTM)	5.14	4.37	3.11	2.21	2.11
ASND's Total Ranking	# 4294	# 0	#	#	#
Accounts Receivable average collection period days	71	84	117	165	173
Seq. Receivable Change	0 %	0 %	0 %	-15 %	0 %
Seq. Revenue Change	11.76 %	39.27 %	68.6 %	-43.17 %	194.42 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 222
Healthcare Sector	# 607
Overall Market	# 4294

Receivable Turnover Ratio Statistics
High	Average	Low
17.97	4.17	0.1
(Dec 31 2020)		(Dec 31 2021)

ASND Company Profile • Back to ASND Efficiency Comparisons • Compare ASND Receivables Turnover Ratio to its Competitors

Financial Statements
Ascendis Pharma A's Accounts Receivable	$ 158 Millions	Visit ASND's Balance sheet
Ascendis Pharma A's Sales TTM	$ 814 Millions	Visit ASND's Income Statement
Sources of ASND's Revenues		Visit ASND's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ASND's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ASND's Growth Rates	ASND's Roa	ASND's Inventory Turnover Ratio	ASND's Dividend Comparisons
ASND's Profitability Ratios	ASND's Roi	ASND's Asset Turnover Ratio	ASND's Dividend Growth
ASND's Valuation Ratios	ASND's Roe	ASND's Financial Strength Ratios	ASND's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2025	Receivable at quarter ending Dec 31 2025
Sutro Biopharma Inc	13.92	$ 102.484 Millions	$ 7.365 Millions
Amneal Pharmaceuticals Inc	13.44	$ 3,018.308 Millions	$ 224.629 Millions
10x Genomics Inc	13.28	$ 641.881 Millions	$ 48.330 Millions
Rosecliff Acquisition Corp I	13.19	$ 20.547 Millions	$ 1.557 Millions
Xoma Royalty Corporation	13.18	$ 52.149 Millions	$ 3.957 Millions
Nexgel Inc	13.17	$ 10.509 Millions	$ 0.798 Millions
Skinhealth Systems Inc	13.02	$ 300.364 Millions	$ 23.063 Millions
Milestone Scientific Inc	12.98	$ 8.408 Millions	$ 0.648 Millions
Mannkind Corporation	12.49	$ 348.966 Millions	$ 27.948 Millions
Zomedica Corp	12.48	$ 31.278 Millions	$ 2.506 Millions
Lftd Partners Inc	12.48	$ 36.921 Millions	$ 2.959 Millions
Safe Pro Group Inc	12.46	$ 0.607 Millions	$ 0.049 Millions
Icu Medical Inc	12.35	$ 2,231.262 Millions	$ 180.620 Millions
Neuroone Medical Technologies Corp	12.24	$ 8.716 Millions	$ 0.712 Millions
Ptc Therapeutics inc	11.92	$ 1,730.655 Millions	$ 145.207 Millions
Corcept Therapeutics Inc	11.91	$ 761.407 Millions	$ 63.950 Millions
Option Care Health Inc	11.86	$ 5,648.895 Millions	$ 476.492 Millions
Cytokinetics Incorporated	11.74	$ 88.039 Millions	$ 7.499 Millions
Teladoc Health Inc	11.74	$ 2,529.977 Millions	$ 215.496 Millions
Lifestance Health Group Inc	11.71	$ 1,424.285 Millions	$ 121.659 Millions
Chemed Corporation	11.65	$ 2,529.978 Millions	$ 217.224 Millions
Ethema Health Corporation	11.64	$ 18.765 Millions	$ 1.612 Millions
Orthofix Medical Inc	11.58	$ 822.017 Millions	$ 71.016 Millions
Lucid Diagnostics Inc	11.57	$ 4.706 Millions	$ 0.407 Millions
Grifols Sa	11.56	$ 8,426.880 Millions	$ 729.120 Millions
Nrc Health	11.55	$ 137.390 Millions	$ 11.900 Millions
Lifeloc Technologies Inc	11.41	$ 9.027 Millions	$ 0.791 Millions
Petvivo Holdings Inc	11.10	$ 0.791 Millions	$ 0.071 Millions
Uniqure N v	10.98	$ 16.098 Millions	$ 1.466 Millions
Inmed Pharmaceuticals Inc	10.98	$ 4.507 Millions	$ 0.410 Millions

Date modified: 2026-09-18T14:10:37+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.